Literature DB >> 32146067

Complex Evolution of Epidemiology of Vascular Diseases, Including Increased Disease Burden: From 2000 to 2015.

Claudia Blais1, Louis Rochette2, Suzie Ouellet3, Thao Huynh4.   

Abstract

BACKGROUND: Vascular diseases, encompassing coronary heart disease (CHD), cerebrovascular disease (CVD), and peripheral artery disease (PAD), are leading causes of the global mortality and morbidity burdens. Our objective was to evaluate the temporal trends in the burden of vascular diseases in the province of Quebec from 2000 to 2015.
METHODS: We identified subjects aged ≥ 20 years with vascular diseases in the Quebec Integrated Chronic Disease Surveillance System (a combination of 5 provincial health administrative datasets). We identified Quebecers with CHD, CVD, or PAD by tracking codes identifying vascular diseases (and interventions for CHD) in the hospitalization datasets. We used the 2011 Quebec standard population for age standardization.
RESULTS: In 2015, the crude prevalence of vascular diseases was 7.3% (n = 473,305), and the all-cause crude mortality rate was 6.6% (n = 31,320). Age-standardized prevalence of vascular diseases increased relatively by 21.4% between 2000 (5.6%; 99% confidence interval [CI], 5.5-5.6) and 2015 (6.8%; 99% CI, 6.7-6.8), whereas the age-standardized incidence and mortality rates showed relative decreases of 46.2% and 32.6%, respectively. PAD and CVD had lower prevalence and incidence but higher mortality than CHD. Most patients with CHD only had this vascular disease in contrast to patients with PAD who generally had diseases involving more than 1 vascular bed. CHD only and CHD with PAD ranked first and second, respectively, in mortality burdens.
CONCLUSIONS: During the last decade, the age-standardized incidence and mortality rate of vascular diseases declined, but their prevalence increased with the overall burden of vascular diseases remaining substantial in Quebec, Canada.
Copyright © 2019 Canadian Cardiovascular Society. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 32146067     DOI: 10.1016/j.cjca.2019.10.021

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  6 in total

Review 1.  History, progress and future challenges of artificial blood vessels: a narrative review.

Authors:  Ke Hu; Yuxuan Li; Zunxiang Ke; Hongjun Yang; Chanjun Lu; Yiqing Li; Yi Guo; Weici Wang
Journal:  Biomater Transl       Date:  2022-03-28

Review 2.  Sex as a Key Determinant of Peripheral Artery Disease: Epidemiology, Differential Outcomes, and Proposed Biological Mechanisms.

Authors:  Amanda Morrison; Aaron W Aday
Journal:  Can J Cardiol       Date:  2022-02-26       Impact factor: 6.614

3.  An Integrative Pharmacology-Based Strategy to Uncover the Mechanism of Xiong-Pi-Fang in Treating Coronary Heart Disease with Depression.

Authors:  Lihong Zhang; Yu Zhang; Mingdan Zhu; Limin Pei; Fangjun Deng; JinHong Chen; Shaoqiang Zhang; Zidong Cong; Wuxun Du; Xuefeng Xiao
Journal:  Front Pharmacol       Date:  2021-04-01       Impact factor: 5.810

4.  Association between the platelet-lymphocyte ratio and short-term mortality in patients with non-ST-segment elevation myocardial infarction.

Authors:  Zhongyuan Meng; Jiaqiang Yang; Jianfu Wu; Xifeng Zheng; Yaxin Zhao; Yan He
Journal:  Clin Cardiol       Date:  2021-05-26       Impact factor: 2.882

5.  Increasing Prevalence and Incidence of Atherosclerotic Cardiovascular Disease in Adult Patients in Ontario, Canada From 2002 to 2018.

Authors:  Erin S Mackinnon; Ron Goeree; Shaun G Goodman; Raina M Rogoza; Millicent Packalen; Louisa Pericleous; Ponda Motsepe-Ditshego; Paul Oh
Journal:  CJC Open       Date:  2021-10-20

6.  Depression increased risk of coronary heart disease: A meta-analysis of prospective cohort studies.

Authors:  Hongfu Cao; Hui Zhao; Li Shen
Journal:  Front Cardiovasc Med       Date:  2022-08-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.